Keros Therapeutics Inc (KROS)

Change in Working Capital

$8.18M

TTM · Period ending: · USD

KROS logo

KROS Change in Working Capital

Latest reported$8.18M
KROS TTM Change in Working Capital (-$6.72M → $8.18M)
High-resolution chart · PNG

KROS change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
8,179,000
-2,099,000
-12,111,000
-10,038,000
-2,815,000
1,624,000
-11,437,000
5,527,000
-11,039,000
-7,971,000
-2,650,000
-6,448,000
-8,839,000
-8,558,000
14,308,000
-5,729,000
3,724,000
-722,000
-16,070,000
1,877,000
-1,746,000
2,864,000
2,275,000
-2,406,000
-2,109,000
-4,567,000
-6,724,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.